This page in Swedish

Research projects

Ketamine as an Alternative Treatment to ECT in Major Depressive Disorder

About this project

Project information

Project status

In progress

Contact

Axel Nordenskjöld

Research subject

Developing more effective and faster acting antidepressant is of outmost clinical importance. Available antidepressant therapies have a delayed therapeutic effect. It typically takes several weeks before symptom relief is evident. Furthermore, antidepressants are relatively ineffective - as many as 30% of patients do not respond to any medication at all. In this study the investigators evaluate the NMDA-receptor antagonist ketamine as a potentially new antidepressant treatment for severely depressed patients and compare its effectiveness with that of electroconvulsive therapy (ECT).

More information